Triple-negative breast cancer (TNBC) is a phenotypic subtype defined by a lack of hormonal (estrogen and progesterone) receptors and human epidermal growth factor receptor 2 (HER2) expression that accounts for 10% to 20% of all breast cancers (BC) (1–3). The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.